Middle East & Africa Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis

The Middle East & Africa Donor Blood Component Market is projected to grow significantly, reaching an estimated US$ 525.2 million by 2031, up from US$ 384.6 million in 2024. This growth represents a compound annual growth rate (CAGR) of 4.7% from 2025 to 2031.

### Executive Summary and Market Analysis
The donor blood component market in the Middle East & Africa is primarily segmented into key regions including the UAE, Saudi Arabia, South Africa, and the Rest of the Middle East & Africa. Factors such as rapid population growth and enhanced access to healthcare services are driving an increase in transfusion needs across the region. Government initiatives and heightened awareness regarding voluntary blood donation are also playing a crucial role in improving blood collection efforts. Furthermore, the expansion of advanced healthcare infrastructure, particularly in Gulf countries, is bolstering market growth.

The rising incidence of chronic diseases, such as leukemia and sickle cell disease, along with trauma cases and surgical procedures, has led to a heightened demand for blood components, including red blood cells, platelets, and plasma. Additionally, increased investments from both public and private sectors, along with international partnerships and support from various organizations, are strengthening blood supply systems throughout the region, further propelling the donor blood component market.

### Strategic Insights
#### Market Segmentation Analysis

The Middle East & Africa Donor Blood Component Market is segmented by various criteria:

**By Blood Component**: The market is divided into Red Blood Cells, White Blood Cells, Platelets, Plasma, and Others. Red Blood Cells are expected to hold the largest market share in 2024.
**By Blood Component Volume**: Similar to the above, Red Blood Cells are anticipated to dominate this segment as well.
**By Indication**: The market is categorized into Immunosuppression and Oncology, with Immunosuppression expected to hold the largest share in 2024.
**By Immunosuppression**: This segment includes Organ Transplant, HIV/AIDS, Autoimmune Disease, Cardiovascular Surgeries, Orthopedic Surgeries, and Others, with HIV/AIDS projected to lead in market share.
**By Oncology**: The market is divided into Hematologic malignancies and Solid Tumor Patients, with Hematologic malignancies expected to dominate.
**By Application**: This includes Anemia management, Thrombocytopenia treatment, Coagulopathy correction, Supportive care during chemotherapy, Surgery, and Others, with Anemia management anticipated to hold the largest share.
**By Age Group**: The market is segmented into Adult and Child, with Adults expected to dominate.
**By End User**: This includes Hospitals, Oncology centers, Transplant centers, Ambulatory surgical centers, and Others, with Hospitals projected to hold the largest share.

### Market Outlook
The increasing prevalence of cancer and immunosuppressive diseases is significantly driving the demand for blood components such as platelets and plasma. Patients undergoing chemotherapy or immunosuppressive treatments often require frequent transfusions, which is a key driver of the donor blood component market. The global incidence of cancer and immunosuppressive disorders is on the rise, with cancer patients frequently needing RBC and platelet transfusions due to the adverse effects of treatments like chemotherapy and radiation.

According to the Joint United Nations Program on HIV/AIDS (UNAIDS), over 39.9 million individuals were living with HIV worldwide in 2023, many of whom rely on blood components for survival. Furthermore, GLOBOCAN estimates suggest that by 2040, there will be over 28.4 million new cancer cases annually, which will further increase the demand for blood components in treatment centers and hospitals. The aging population, which is more susceptible to cancer and immunosuppressive illnesses, also drives the need for a reliable blood supply.

### Country Insights
The market is segmented by country, with Saudi Arabia, South Africa, the UAE, and the Rest of the Middle East & Africa being the key regions. South Africa is expected to hold the largest market share in 2024. Notably, sickle cell disease has a high incidence in sub-Saharan Africa, with approximately 270,000 babies born with the condition each year. Patients with sickle cell disease often require frequent blood transfusions to manage complications, thereby increasing the demand for blood components.

In South Africa, GLOBOCAN 2022 data reported 2,022 new leukemia cases and 1,719 leukemia-related deaths in 2022. Treatments for leukemia often necessitate blood component transfusions, further driving market growth as more patients are diagnosed.

### Key Players
Key players in the Middle East & Africa Donor Blood Component Market include Vitalant, Memorial Sloan Kettering Cancer Center, Roswell Park Comprehensive Cancer Center, Policlinico of Milan, MD Anderson Cancer Center, The Johns Hopkins Hospital, The Royal Marsden, Gustave Roussy, Peter MacCallum Cancer Centre, and Tata Memorial Hospital. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their market presence and offer innovative solutions to consumers.

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macroeconomic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country-level data:

4. Donor Blood Component Market Landscape

4.1 Market Overview
4.2 PEST Analysis
4.3 Average Selling Price Per Unit (US$) of Blood Components, 2024
4.4 Global Disease Prevalence of 5 Key Diseases, 2024

5. Middle East & Africa Donor Blood Component Market - Key Market Dynamics

5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints:

6. Donor Blood Component Market - Middle East & Africa Market Analysis

6.1 Middle East & Africa Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
6.2 Middle East & Africa Donor Blood Component Market Forecast and Analysis

7. Middle East & Africa Donor Blood Component Market Revenue Analysis - by Blood Component

7.1 Red Blood Cells
7.1.1 Overview
7.1.2 Red Blood Cells: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.2 White blood cells
7.2.1 Overview
7.2.2 White blood cells: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.3 Platelets
7.3.1 Overview
7.3.2 Platelets: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.4 Plasma
7.4.1 Overview
7.4.2 Plasma: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

8. Middle East & Africa Donor Blood Component Market Revenue Analysis - by Blood Component Volume

8.1 Red Blood Cells
8.1.1 Overview
8.1.2 Red Blood Cells: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.2 White blood cells
8.2.1 Overview
8.2.2 White blood cells: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.3 Platelets
8.3.1 Overview
8.3.2 Platelets: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.4 Plasma
8.4.1 Overview
8.4.2 Plasma: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

9. Middle East & Africa Donor Blood Component Market Revenue Analysis - by Indication

9.1 Immunosuppression
9.1.1 Overview
9.1.2 Immunosuppression: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
9.2 Oncology
9.2.1 Overview
9.2.2 Oncology: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

10. Middle East & Africa Donor Blood Component Market Revenue Analysis - by Immunosuppression

10.1 Organ Transplant
10.1.1 Overview
10.1.2 Organ Transplant: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.2 HIV or AIDS
10.2.1 Overview
10.2.2 HIV or AIDS: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.3 Autoimmune Disease
10.3.1 Overview
10.3.2 Autoimmune Disease: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.4 Cardiovascular Surgeries
10.4.1 Overview
10.4.2 Cardiovascular Surgeries: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.5 Orthopedic Surgeries
10.5.1 Overview
10.5.2 Orthopedic Surgeries: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

11. Middle East & Africa Donor Blood Component Market Revenue Analysis - by Oncology

11.1 Hematologic malignancies
11.1.1 Overview
11.1.2 Hematologic malignancies: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
11.2 Solid Tumor Patients
11.2.1 Overview
11.2.2 Solid Tumor Patients: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

12. Middle East & Africa Donor Blood Component Market Revenue Analysis - by Application

12.1 Anemia management
12.1.1 Overview
12.1.2 Anemia management: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.2 Thrombocytopenia treatment
12.2.1 Overview
12.2.2 Thrombocytopenia treatment: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.3 Coagulopathy correction
12.3.1 Overview
12.3.2 Coagulopathy correction: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.4 Supportive care during chemotherapy
12.4.1 Overview
12.4.2 Supportive care during chemotherapy: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.5 Surgery
12.5.1 Overview
12.5.2 Surgery: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
12.6 Others
12.6.1 Overview
12.6.2 Others: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

13. Middle East & Africa Donor Blood Component Market Revenue Analysis - by Age Group

13.1 Adult
13.1.1 Overview
13.1.2 Adult: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
13.2 Child
13.2.1 Overview
13.2.2 Child: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

14. Middle East & Africa Donor Blood Component Market Revenue Analysis - by End User

14.1 Hospitals
14.1.1 Overview
14.1.2 Hospitals: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.2 Oncology centers
14.2.1 Overview
14.2.2 Oncology centers: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.3 Transplant centers
14.3.1 Overview
14.3.2 Transplant centers: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.4 Ambulatory surgical centers
14.4.1 Overview
14.4.2 Ambulatory surgical centers: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
14.5 Others
14.5.1 Overview
14.5.2 Others: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

15. Middle East & Africa Donor Blood Component Market - Country Analysis

15.1 Middle East & Africa
15.1.1 Middle East & Africa Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.1.1 Middle East & Africa Donor Blood Component Market Revenue and Forecast and Analysis - by Country
15.1.2.2 Saudi Arabia: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.1.2.2.1 Saudi Arabia: Middle East & Africa Donor Blood Component Market Share - by Blood Component
15.1.2.2.2 Saudi Arabia: Middle East & Africa Donor Blood Component Market Share - by Blood Component Volume
15.1.2.2.3 Saudi Arabia: Middle East & Africa Donor Blood Component Market Share - by Indication
15.1.2.2.4 Saudi Arabia: Middle East & Africa Donor Blood Component Market Share - by Immunosuppression
15.1.2.2.5 Saudi Arabia: Middle East & Africa Donor Blood Component Market Share - by Oncology
15.1.2.2.6 Saudi Arabia: Middle East & Africa Donor Blood Component Market Share - by Application
15.1.2.2.7 Saudi Arabia: Middle East & Africa Donor Blood Component Market Share - by Age Group
15.1.2.2.8 Saudi Arabia: Middle East & Africa Donor Blood Component Market Share - by End User
15.2.3.3 South Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.2.3.3.1 South Africa: Middle East & Africa Donor Blood Component Market Share - by Blood Component
15.2.3.3.2 South Africa: Middle East & Africa Donor Blood Component Market Share - by Blood Component Volume
15.2.3.3.3 South Africa: Middle East & Africa Donor Blood Component Market Share - by Indication
15.2.3.3.4 South Africa: Middle East & Africa Donor Blood Component Market Share - by Immunosuppression
15.2.3.3.5 South Africa: Middle East & Africa Donor Blood Component Market Share - by Oncology
15.2.3.3.6 South Africa: Middle East & Africa Donor Blood Component Market Share - by Application
15.2.3.3.7 South Africa: Middle East & Africa Donor Blood Component Market Share - by Age Group
15.2.3.3.8 South Africa: Middle East & Africa Donor Blood Component Market Share - by End User
15.3.4.4 United Arab Emirates: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.3.4.4.1 United Arab Emirates: Middle East & Africa Donor Blood Component Market Share - by Blood Component
15.3.4.4.2 United Arab Emirates: Middle East & Africa Donor Blood Component Market Share - by Blood Component Volume
15.3.4.4.3 United Arab Emirates: Middle East & Africa Donor Blood Component Market Share - by Indication
15.3.4.4.4 United Arab Emirates: Middle East & Africa Donor Blood Component Market Share - by Immunosuppression
15.3.4.4.5 United Arab Emirates: Middle East & Africa Donor Blood Component Market Share - by Oncology
15.3.4.4.6 United Arab Emirates: Middle East & Africa Donor Blood Component Market Share - by Application
15.3.4.4.7 United Arab Emirates: Middle East & Africa Donor Blood Component Market Share - by Age Group
15.3.4.4.8 United Arab Emirates: Middle East & Africa Donor Blood Component Market Share - by End User
15.4.5.5 Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
15.4.5.5.1 Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market Share - by Blood Component
15.4.5.5.2 Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market Share - by Blood Component Volume
15.4.5.5.3 Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market Share - by Indication
15.4.5.5.4 Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market Share - by Immunosuppression
15.4.5.5.5 Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market Share - by Oncology
15.4.5.5.6 Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market Share - by Application
15.4.5.5.7 Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market Share - by Age Group
15.4.5.5.8 Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market Share - by End User

17 Industry Landscape

17.1 Overview
17.2 New Product Development
17.3 Merger and Acquisition
17.4 Other Strategic Developments

18 COMPANY PROFILES

18.1 Vitalant
18.1.1 Key Facts
18.1.2 Business Description
18.1.3 Products and Services
18.1.4 Financial Overview
18.1.5 SWOT Analysis
18.1.6 Key Developments
18.2 Memorial Sloan Kettering Cancer Center
18.2.1 Key Facts
18.2.2 Business Description
18.2.3 Products and Services
18.2.4 Financial Overview
18.2.5 SWOT Analysis
18.2.6 Key Developments
18.3 Roswell Park Comprehensive Cancer Center
18.3.1 Key Facts
18.3.2 Business Description
18.3.3 Products and Services
18.3.4 Financial Overview
18.3.5 SWOT Analysis
18.3.6 Key Developments
18.4 Policlinico of Milan
18.4.1 Key Facts
18.4.2 Business Description
18.4.3 Products and Services
18.4.4 Financial Overview
18.4.5 SWOT Analysis
18.4.6 Key Developments
18.5 MD Anderson Cancer Center.
18.5.1 Key Facts
18.5.2 Business Description
18.5.3 Products and Services
18.5.4 Financial Overview
18.5.5 SWOT Analysis
18.5.6 Key Developments
18.6 The Johns Hopkins Hospital
18.6.1 Key Facts
18.6.2 Business Description
18.6.3 Products and Services
18.6.4 Financial Overview
18.6.5 SWOT Analysis
18.6.6 Key Developments
18.7 The Royal Marsden
18.7.1 Key Facts
18.7.2 Business Description
18.7.3 Products and Services
18.7.4 Financial Overview
18.7.5 SWOT Analysis
18.7.6 Key Developments
18.8 Gustave Roussy
18.8.1 Key Facts
18.8.2 Business Description
18.8.3 Products and Services
18.8.4 Financial Overview
18.8.5 SWOT Analysis
18.8.6 Key Developments
18.9 Peter MacCallum Cancer Centre
18.9.1 Key Facts
18.9.2 Business Description
18.9.3 Products and Services
18.9.4 Financial Overview
18.9.5 SWOT Analysis
18.9.6 Key Developments
18.10 Tata Memorial Hospital
18.10.1 Key Facts
18.10.2 Business Description
18.10.3 Products and Services
18.10.4 Financial Overview
18.10.5 SWOT Analysis
18.10.6 Key Developments

19. Appendix

19.1 About the Analyst

LIST OF TABLES

Table 1. Middle East & Africa Donor Blood Component Market Segmentation
Table 3. Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Table 4. Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 5. Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 6. Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 7. Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 8. Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 9. Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 10. Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 11. Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 12. Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Country
Table 13. Saudi Arabia: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 14. Saudi Arabia: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 15. Saudi Arabia: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 16. Saudi Arabia: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 17. Saudi Arabia: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 18. Saudi Arabia: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 19. Saudi Arabia: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 20. Saudi Arabia: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 21. South Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 22. South Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 23. South Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 24. South Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 25. South Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 26. South Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 27. South Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 28. South Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 29. United Arab Emirates: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 30. United Arab Emirates: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 31. United Arab Emirates: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 32. United Arab Emirates: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 33. United Arab Emirates: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 34. United Arab Emirates: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 35. United Arab Emirates: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 36. United Arab Emirates: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User
Table 37. Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component
Table 38. Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Blood Component Volume
Table 39. Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Indication
Table 40. Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Immunosuppression
Table 41. Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Oncology
Table 42. Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Application
Table 43. Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Age Group
Table 44. Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by End User

LIST OF FIGURES

Figure 1. Middle East & Africa Donor Blood Component Market Segmentation - Country
Figure 2. PEST Analysis
Figure 4. Middle East & Africa Donor Blood Component Market - Key Market Dynamics
Figure 5. Impact Analysis of Drivers and Restraints
Figure 6. Middle East & Africa Donor Blood Component Market Revenue (US$ Million), 2024 - 2031
Figure 7. Middle East & Africa Donor Blood Component Market Share (%) - by Blood Component, 2024 and 2031
Figure 8. Red Blood Cells: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 9. White blood cells: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 10. Platelets: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 11. Plasma: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 12. Others: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 13. Middle East & Africa Donor Blood Component Market Share (%) - by Blood Component Volume, 2024 and 2031
Figure 14. Red Blood Cells: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 15. White blood cells: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 16. Platelets: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 17. Plasma: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 18. Others: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 19. Middle East & Africa Donor Blood Component Market Share (%) - by Indication, 2024 and 2031
Figure 20. Immunosuppression: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 21. Oncology: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 22. Middle East & Africa Donor Blood Component Market Share (%) - by Immunosuppression, 2024 and 2031
Figure 23. Organ Transplant: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 24. HIV or AIDS: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 25. Autoimmune Disease: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 26. Cardiovascular Surgeries: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 27. Orthopedic Surgeries: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 28. Others: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 29. Middle East & Africa Donor Blood Component Market Share (%) - by Oncology, 2024 and 2031
Figure 30. Hematologic malignancies: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 31. Solid Tumor Patients: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 32. Middle East & Africa Donor Blood Component Market Share (%) - by Application, 2024 and 2031
Figure 33. Anemia management: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 34. Thrombocytopenia treatment: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 35. Coagulopathy correction: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 36. Supportive care during chemotherapy: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 37. Surgery: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 38. Others: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 39. Middle East & Africa Donor Blood Component Market Share (%) - by Age Group, 2024 and 2031
Figure 40. Adult: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 41. Child: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 42. Middle East & Africa Donor Blood Component Market Share (%) - by End User, 2024 and 2031
Figure 43. Hospitals: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 44. Oncology centers: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 45. Transplant centers: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 46. Ambulatory surgical centers: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 47. Others: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 48. Middle East & Africa Donor Blood Component Market Breakdown by Key Countries, 2024 and 2031 (%)
Figure 49. Saudi Arabia: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 50. South Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 51. United Arab Emirates: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)
Figure 52. Rest of Middle East & Africa: Middle East & Africa Donor Blood Component Market - Revenue and Forecast, 2021 - 2031 (US$ Million)

Companies

The List of Companies - Middle East & Africa Donor Blood Component Market

Vitalant

Memorial Sloan Kettering Cancer Center

Roswell Park Comprehensive Cancer Center

Policlinico of Milan

MD Anderson Cancer Center.

The Johns Hopkins Hospital

The Royal Marsden

Gustave Roussy

Peter MacCallum Cancer Centre

Tata Memorial Hospital

License	Format	Properties	Price
SINGLE USER LICENSE PDF	The product is a PDF.	This is a single user license, allowing one user access to the product.	€3173EUR$3,450USD£2,704GBP
SITE LICENSE PDF	The product is a PDF.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€4093EUR$4,450USD£3,487GBP
ENTERPRISE LICENSE PDF	The product is a PDF.	This is an enterprise license, allowing all employees within your organization access to the product.	€5013EUR$5,450USD£4,271GBP

The Middle East & Africa Donor Blood Component Market is segmented by various criteria:

Table of Contents

Companies

Related Topics

Related Reports

Donor Blood Components Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: Blood Component, Indication, Application, Age Group, End User, and Geography

Europe Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis

Asia-Pacific Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis

North America Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis

South & Central America Donor Blood Component Market Size and Forecast (2021 - 2031), Regional Share, Trend, and Growth Opportunity Analysis